Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

© 2017 The Authors. Published by Elsevier Ireland Ltd on behalf of European Society of Radiotherapy & Oncology. We present a clinical distance measure for Pareto front evaluation studies in radiotherapy, which we show strongly correlates (r=0.74 and 0.90) with clinical plan quality evaluation. For five prostate cases, sub-optimal treatment plans located at a clinical distance value of > 0.32 (0.28-0.35) from fronts of Pareto optimal plans, were assessed to be of lower plan quality by our (12) observers (p < .05). In conclusion, the clinical distance measure can be used to determine if the difference between a front and a given plan (or between different fronts) corresponds to a clinically significant plan quality difference.

Original publication

DOI

10.1016/j.phro.2017.09.003

Type

Journal article

Journal

Physics and Imaging in Radiation Oncology

Publication Date

01/07/2017

Volume

3

Pages

53 - 56